Hoffman La Roche wins patent war against Cipla in Delhi High Court

Cipla suffered a setback in the Delhi High Court yesterday when a Division Bench of Justices Pradeep Nandrajog & Mukta Gupta held that the pharmaceutical giant had infringed upon Hoffman La Roche’s patent in manufacturing lung cancer drug ‘Erlotinib hydrochloride’ which is also sold under the name of Tarceva.

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com